Review



blocking solution  (Novus Biologicals)


Bioz Verified Symbol Novus Biologicals is a verified supplier
Bioz Manufacturer Symbol Novus Biologicals manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Novus Biologicals blocking solution
    Blocking Solution, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 38 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pla+blocking+solution/Carbo-Free+Blocking+Solution/pm39152101-437-10-20
    Average 94 stars, based on 38 article reviews
    blocking solution - by Bioz Stars, 2026-11
    94/100 stars

    Images

    Related Articles

    Incubation:

    Article Title: Neutrophil extracellular traps drive osteoporosis via NCF2-dependent signaling: integrated transcriptomics with mechanistic validation
    Article Snippet: .. The sections were incubated in a blocking solution to reduce non-specific binding, followed by overnight incubation at 4°C with primary antibodies: VDAC1 (Novus Biologicals, NBP3-15871), PLCG2 (Novus Biologicals, NBP1-86030), and NCF2 (Novus Biologicals, NBP3-16257). .. The sections were incubated in a blocking solution to reduce non-specific binding, followed by overnight incubation at 4°C with primary antibodies: VDAC1 (Novus Biologicals, NBP3-15871), PLCG2 (Novus Biologicals, NBP1-86030), and NCF2 (Novus Biologicals, NBP3-16257).

    Article Title: mTORC1/2 inhibition induces tumor regression in CDK4/6 inhibitor-insensitive acral melanoma.
    Article Snippet: Acral melanoma (AM), a rare and aggressive subtype with 5-year survival rates below 16%, exhibits limited response to CDK4/6 inhibitors (CDK4i/6i) despite frequent pathway alterations.. Here, we identify AKT-mTOR signaling as a critical escape mechanism triggered by CDK4/6 inhibition.. Using a genetically diverse panel of AM cell lines, we demonstrate that CDK4i/6i induces rapid hyperactivation of AKT (pS473) and mTORC1 (pS6 S240/244) alongside Rb dephosphorylation.

    Article Title: Epac1 deletion attenuates Müller glial pathological activation and mitigates retinal neurodegeneration in ischemia-induced retinopathy.
    Article Snippet: .. Briefly, cells on coverslips were blocked with Duolink Blocking Solution for 60 min at 37 °C, followed by overnight incubation at 4 °C with primary antibodies against VEGFR2 (2479) and Biotin (NBP1-46960, Novus Biologicals, Littleton, CO). ..

    Article Title: Senolytic therapy increases replicative capacity by eliminating senescent endothelial cells.
    Article Snippet: .. Subsequently, cells were incubated in the blocking solution with a 1:500 dilution of the 53BP1 antibody (Cat No. NB 100-0304, Rabbit, Novus Biologicals) for 1 hour at room temperature. .. After three washes of 5 minutes each in 1X PBS, the samples were incubated for 1 hour at room temperature with a 1:500 dilution of Alexa Fluor 555 in the blocking solution (Cat No. A21429, Goat anti-Rabbit, Invitrogen).

    Article Title: Induced Mammary Epithelial Cell-Derived Extracellular Vesicles Promote the Repair of Skin Trauma
    Article Snippet: .. After fibroblasts were induced for 8 days, the cells were fixed in 4% paraformaldehyde for 20 min at room temperature, a blocking solution (PBS containing 100 mmol/L glycine and 0.3% BSA) was added, and then, 1% Triton X-100 was added and incubated at room temperature for 15 min. Then, a blocking solution (100 mmol/L glycine and 0.3% BSA in PBS buffer) was added for washing, and the samples were blocked with 1% BSA for 1.5 h at room temperature, followed by the addition of a primary antibody (Mouse monoclonal anti-CK14, NOVUS, Littleton, CO, USA, Cat#NBP2-45032, RRID:AB_3309227 and Mouse monoclonal anti-CK18, NOVUS, Littleton, CO, USA, Cat#NBP2-44951, RRID:AB_2811032), incubation at 4 °C in the refrigerator overnight, and then incubation at room temperature in the dark. .. After incubation with secondary antibody for 1.5 h (Alexa Fluor 488 Donkey Anti-mouse, Abcam, Cambridge, MA, USA, Cat#ab150109; RRID: AB_2571721 and Alexa Fluor 555 Donkey Anti-mouse, Abcam, Cambridge, MA, USA, Cat#ab150100; RRID: AB_2890133), images were taken under a fluorescence microscope and recorded.

    Blocking Assay:

    Article Title: Neutrophil extracellular traps drive osteoporosis via NCF2-dependent signaling: integrated transcriptomics with mechanistic validation
    Article Snippet: .. The sections were incubated in a blocking solution to reduce non-specific binding, followed by overnight incubation at 4°C with primary antibodies: VDAC1 (Novus Biologicals, NBP3-15871), PLCG2 (Novus Biologicals, NBP1-86030), and NCF2 (Novus Biologicals, NBP3-16257). .. The sections were incubated in a blocking solution to reduce non-specific binding, followed by overnight incubation at 4°C with primary antibodies: VDAC1 (Novus Biologicals, NBP3-15871), PLCG2 (Novus Biologicals, NBP1-86030), and NCF2 (Novus Biologicals, NBP3-16257).

    Article Title: mTORC1/2 inhibition induces tumor regression in CDK4/6 inhibitor-insensitive acral melanoma.
    Article Snippet: Acral melanoma (AM), a rare and aggressive subtype with 5-year survival rates below 16%, exhibits limited response to CDK4/6 inhibitors (CDK4i/6i) despite frequent pathway alterations.. Here, we identify AKT-mTOR signaling as a critical escape mechanism triggered by CDK4/6 inhibition.. Using a genetically diverse panel of AM cell lines, we demonstrate that CDK4i/6i induces rapid hyperactivation of AKT (pS473) and mTORC1 (pS6 S240/244) alongside Rb dephosphorylation.

    Article Title: Epac1 deletion attenuates Müller glial pathological activation and mitigates retinal neurodegeneration in ischemia-induced retinopathy.
    Article Snippet: .. Briefly, cells on coverslips were blocked with Duolink Blocking Solution for 60 min at 37 °C, followed by overnight incubation at 4 °C with primary antibodies against VEGFR2 (2479) and Biotin (NBP1-46960, Novus Biologicals, Littleton, CO). ..

    Article Title: Tumor Cell–Intrinsic Decr2 Regulates Ferroptosis and Immunotherapy Efficacy
    Article Snippet: .. The blocking solution was replaced with goat anti–mouse catalase (Novus Biologicals, AF3398-SP), rat anti–mouse Lamp1 (Thermo Fisher Scientific, cat. #14-1071-82) or mouse anti–mouse Atp5a (Abcam, ab14748) and left to incubate overnight at 4°C. .. The blocking solution was replaced with goat anti–mouse catalase (Novus Biologicals, AF3398-SP), rat anti–mouse Lamp1 (Thermo Fisher Scientific, cat. #14-1071-82) or mouse anti–mouse Atp5a (Abcam, ab14748) and left to incubate overnight at 4°C.

    Article Title: Senolytic therapy increases replicative capacity by eliminating senescent endothelial cells.
    Article Snippet: .. Subsequently, cells were incubated in the blocking solution with a 1:500 dilution of the 53BP1 antibody (Cat No. NB 100-0304, Rabbit, Novus Biologicals) for 1 hour at room temperature. .. After three washes of 5 minutes each in 1X PBS, the samples were incubated for 1 hour at room temperature with a 1:500 dilution of Alexa Fluor 555 in the blocking solution (Cat No. A21429, Goat anti-Rabbit, Invitrogen).

    Article Title: Platelet-Rich Plasma (PRP) Mitigates Silver Nanoparticle (AgNP)-Induced Pulmonary Fibrosis via iNOS/CD68/CASP3/TWIST1 Regulation: An Experimental Study and Bioinformatics Analysis.
    Article Snippet: .. The sections were then exposed to blocking solution for 20 min, and an iNOS-recognizing primary antibody (rat monoclonal antibody, 1:500 dilution; Brand: Novus Biologicals, Cat No. NB300-605NCL Transduction Laboratories, San Diego, California, USA) was subsequently added for an additional night at 4 ◦C [73]. .. In accordance with the manufacturer’s instructions, a CD68-recognizing primary antibody (mouse monoclonal antibody, 1:200 dilution; Cat No. ab53444 -L-CD68; Leica Biosystems, Benton La, Newcastle Ltd., UK) was subsequently added to a humidified chamber [74,75].

    Article Title: Induced Mammary Epithelial Cell-Derived Extracellular Vesicles Promote the Repair of Skin Trauma
    Article Snippet: .. After fibroblasts were induced for 8 days, the cells were fixed in 4% paraformaldehyde for 20 min at room temperature, a blocking solution (PBS containing 100 mmol/L glycine and 0.3% BSA) was added, and then, 1% Triton X-100 was added and incubated at room temperature for 15 min. Then, a blocking solution (100 mmol/L glycine and 0.3% BSA in PBS buffer) was added for washing, and the samples were blocked with 1% BSA for 1.5 h at room temperature, followed by the addition of a primary antibody (Mouse monoclonal anti-CK14, NOVUS, Littleton, CO, USA, Cat#NBP2-45032, RRID:AB_3309227 and Mouse monoclonal anti-CK18, NOVUS, Littleton, CO, USA, Cat#NBP2-44951, RRID:AB_2811032), incubation at 4 °C in the refrigerator overnight, and then incubation at room temperature in the dark. .. After incubation with secondary antibody for 1.5 h (Alexa Fluor 488 Donkey Anti-mouse, Abcam, Cambridge, MA, USA, Cat#ab150109; RRID: AB_2571721 and Alexa Fluor 555 Donkey Anti-mouse, Abcam, Cambridge, MA, USA, Cat#ab150100; RRID: AB_2890133), images were taken under a fluorescence microscope and recorded.

    Article Title: In vitro characterization of antimicrobial efficacy and cytotoxicity of polyvinylpyrrolidone-iodine, N-acetylcysteine, methylglyoxal, and N-chlorotaurine as alternative antimicrobials in treating bovine clinical endometritis
    Article Snippet: Then, cells were fixated with 300 μL/well of an ice-cold 1:1 mixture of acetone (Sigma–Aldrich, Steinheim, Germany) and methanol (Avantor Performance Materials Poland, Gliwice, Poland) for 5 min. As a next step, cells were blocked at room temperature with 300 μL/well of a blocking solution consisting of 0.25% Triton X-100 (Sigma–Aldrich, Steinheim, Germany) and 1% BSA in PBS. .. After removing the blocking solution, the first antibody, a primary mouse pan-anticytokeratin (C11; Novus Biologicals, Wiesbaden, Germany), was diluted 1:100 in the blocking solution and added to wells 1 and 3 at 150 μL/well. ..

    Binding Assay:

    Article Title: Neutrophil extracellular traps drive osteoporosis via NCF2-dependent signaling: integrated transcriptomics with mechanistic validation
    Article Snippet: .. The sections were incubated in a blocking solution to reduce non-specific binding, followed by overnight incubation at 4°C with primary antibodies: VDAC1 (Novus Biologicals, NBP3-15871), PLCG2 (Novus Biologicals, NBP1-86030), and NCF2 (Novus Biologicals, NBP3-16257). .. The sections were incubated in a blocking solution to reduce non-specific binding, followed by overnight incubation at 4°C with primary antibodies: VDAC1 (Novus Biologicals, NBP3-15871), PLCG2 (Novus Biologicals, NBP1-86030), and NCF2 (Novus Biologicals, NBP3-16257).

    Transduction:

    Article Title: Platelet-Rich Plasma (PRP) Mitigates Silver Nanoparticle (AgNP)-Induced Pulmonary Fibrosis via iNOS/CD68/CASP3/TWIST1 Regulation: An Experimental Study and Bioinformatics Analysis.
    Article Snippet: .. The sections were then exposed to blocking solution for 20 min, and an iNOS-recognizing primary antibody (rat monoclonal antibody, 1:500 dilution; Brand: Novus Biologicals, Cat No. NB300-605NCL Transduction Laboratories, San Diego, California, USA) was subsequently added for an additional night at 4 ◦C [73]. .. In accordance with the manufacturer’s instructions, a CD68-recognizing primary antibody (mouse monoclonal antibody, 1:200 dilution; Cat No. ab53444 -L-CD68; Leica Biosystems, Benton La, Newcastle Ltd., UK) was subsequently added to a humidified chamber [74,75].



    Similar Products

    93
    Santa Cruz Biotechnology pla blocking solution
    Loss of BTG3 leads to reduced mobility of XPC at damage sites. ( A – C ) Colocalization of BTG3 and XPC at damage sites after UV. <t>PLA</t> was conducted <t>with</t> <t>HaCaT</t> cells using anti-BTG3 and anti-XPC (A). Mean fluorescence intensity and PLA foci number were quantified and shown in panels (B) and (C), respectively, with n ≧ 100. Data were analyzed using unpaired two-tailed t -test and presented as mean ± SEM Scale bar, 10 μm. ( D ) Co-immunoprecipitation of endogenous BTG3 and XPC from HaCaT cells. ( E, F ) Retention of XPC at localized UV damage in BTG3 KO cells. Localized UVC-irradiation (100 J/m 2 ) was performed with 5 μM isopore membrane filter and XPC loading at localized UV damage sites was assessed using confocal microscopy (E). Scale bar, 10 μm. Percent cells with XPC-positive foci were counted and presented as mean ± SEM in panel (F). Data were analyzed using unpaired two-tailed t -test. n ≧ 50. ( G, H ) Mobility of XPC was reduced in BTG3 KO cells. The mobility of XPC-GFP in mock-treated or global UV-irradiated (20 J/m 2 ) parental and BTG3 KO HEK293T cells was assessed using FRAP. Fluorescence recovery was monitored over 120 s and normalized to prebleach intensity ( n = 36 from 3 independent experiments) (G). Data were analyzed using unpaired two-tailed t -tests and shown as mean ± SEM in panel (H).
    Pla Blocking Solution, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pla+blocking+solution/Polylactic+acid/pmc12235512-148-3-12
    Average 93 stars, based on 1 article reviews
    pla blocking solution - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    90
    Millipore pla blocking solution
    Loss of BTG3 leads to reduced mobility of XPC at damage sites. ( A – C ) Colocalization of BTG3 and XPC at damage sites after UV. <t>PLA</t> was conducted <t>with</t> <t>HaCaT</t> cells using anti-BTG3 and anti-XPC (A). Mean fluorescence intensity and PLA foci number were quantified and shown in panels (B) and (C), respectively, with n ≧ 100. Data were analyzed using unpaired two-tailed t -test and presented as mean ± SEM Scale bar, 10 μm. ( D ) Co-immunoprecipitation of endogenous BTG3 and XPC from HaCaT cells. ( E, F ) Retention of XPC at localized UV damage in BTG3 KO cells. Localized UVC-irradiation (100 J/m 2 ) was performed with 5 μM isopore membrane filter and XPC loading at localized UV damage sites was assessed using confocal microscopy (E). Scale bar, 10 μm. Percent cells with XPC-positive foci were counted and presented as mean ± SEM in panel (F). Data were analyzed using unpaired two-tailed t -test. n ≧ 50. ( G, H ) Mobility of XPC was reduced in BTG3 KO cells. The mobility of XPC-GFP in mock-treated or global UV-irradiated (20 J/m 2 ) parental and BTG3 KO HEK293T cells was assessed using FRAP. Fluorescence recovery was monitored over 120 s and normalized to prebleach intensity ( n = 36 from 3 independent experiments) (G). Data were analyzed using unpaired two-tailed t -tests and shown as mean ± SEM in panel (H).
    Pla Blocking Solution, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pla+blocking+solution/pla+blocking+solution/pm37965896-429-7-10
    Average 90 stars, based on 1 article reviews
    pla blocking solution - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Merck & Co blocking solution included pla kit (duolink situ probe
    Loss of BTG3 leads to reduced mobility of XPC at damage sites. ( A – C ) Colocalization of BTG3 and XPC at damage sites after UV. <t>PLA</t> was conducted <t>with</t> <t>HaCaT</t> cells using anti-BTG3 and anti-XPC (A). Mean fluorescence intensity and PLA foci number were quantified and shown in panels (B) and (C), respectively, with n ≧ 100. Data were analyzed using unpaired two-tailed t -test and presented as mean ± SEM Scale bar, 10 μm. ( D ) Co-immunoprecipitation of endogenous BTG3 and XPC from HaCaT cells. ( E, F ) Retention of XPC at localized UV damage in BTG3 KO cells. Localized UVC-irradiation (100 J/m 2 ) was performed with 5 μM isopore membrane filter and XPC loading at localized UV damage sites was assessed using confocal microscopy (E). Scale bar, 10 μm. Percent cells with XPC-positive foci were counted and presented as mean ± SEM in panel (F). Data were analyzed using unpaired two-tailed t -test. n ≧ 50. ( G, H ) Mobility of XPC was reduced in BTG3 KO cells. The mobility of XPC-GFP in mock-treated or global UV-irradiated (20 J/m 2 ) parental and BTG3 KO HEK293T cells was assessed using FRAP. Fluorescence recovery was monitored over 120 s and normalized to prebleach intensity ( n = 36 from 3 independent experiments) (G). Data were analyzed using unpaired two-tailed t -tests and shown as mean ± SEM in panel (H).
    Blocking Solution Included Pla Kit (Duolink Situ Probe, supplied by Merck & Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pla+blocking+solution/duo92002/pm37604854-260-41-52
    Average 90 stars, based on 1 article reviews
    blocking solution included pla kit (duolink situ probe - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Millipore duolink pla blocking solution
    Loss of BTG3 leads to reduced mobility of XPC at damage sites. ( A – C ) Colocalization of BTG3 and XPC at damage sites after UV. <t>PLA</t> was conducted <t>with</t> <t>HaCaT</t> cells using anti-BTG3 and anti-XPC (A). Mean fluorescence intensity and PLA foci number were quantified and shown in panels (B) and (C), respectively, with n ≧ 100. Data were analyzed using unpaired two-tailed t -test and presented as mean ± SEM Scale bar, 10 μm. ( D ) Co-immunoprecipitation of endogenous BTG3 and XPC from HaCaT cells. ( E, F ) Retention of XPC at localized UV damage in BTG3 KO cells. Localized UVC-irradiation (100 J/m 2 ) was performed with 5 μM isopore membrane filter and XPC loading at localized UV damage sites was assessed using confocal microscopy (E). Scale bar, 10 μm. Percent cells with XPC-positive foci were counted and presented as mean ± SEM in panel (F). Data were analyzed using unpaired two-tailed t -test. n ≧ 50. ( G, H ) Mobility of XPC was reduced in BTG3 KO cells. The mobility of XPC-GFP in mock-treated or global UV-irradiated (20 J/m 2 ) parental and BTG3 KO HEK293T cells was assessed using FRAP. Fluorescence recovery was monitored over 120 s and normalized to prebleach intensity ( n = 36 from 3 independent experiments) (G). Data were analyzed using unpaired two-tailed t -tests and shown as mean ± SEM in panel (H).
    Duolink Pla Blocking Solution, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pla+blocking+solution/duolink+pla/pm37480622-106-6-10
    Average 90 stars, based on 1 article reviews
    duolink pla blocking solution - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Millipore blocking solution supplied pla kit
    Loss of BTG3 leads to reduced mobility of XPC at damage sites. ( A – C ) Colocalization of BTG3 and XPC at damage sites after UV. <t>PLA</t> was conducted <t>with</t> <t>HaCaT</t> cells using anti-BTG3 and anti-XPC (A). Mean fluorescence intensity and PLA foci number were quantified and shown in panels (B) and (C), respectively, with n ≧ 100. Data were analyzed using unpaired two-tailed t -test and presented as mean ± SEM Scale bar, 10 μm. ( D ) Co-immunoprecipitation of endogenous BTG3 and XPC from HaCaT cells. ( E, F ) Retention of XPC at localized UV damage in BTG3 KO cells. Localized UVC-irradiation (100 J/m 2 ) was performed with 5 μM isopore membrane filter and XPC loading at localized UV damage sites was assessed using confocal microscopy (E). Scale bar, 10 μm. Percent cells with XPC-positive foci were counted and presented as mean ± SEM in panel (F). Data were analyzed using unpaired two-tailed t -test. n ≧ 50. ( G, H ) Mobility of XPC was reduced in BTG3 KO cells. The mobility of XPC-GFP in mock-treated or global UV-irradiated (20 J/m 2 ) parental and BTG3 KO HEK293T cells was assessed using FRAP. Fluorescence recovery was monitored over 120 s and normalized to prebleach intensity ( n = 36 from 3 independent experiments) (G). Data were analyzed using unpaired two-tailed t -tests and shown as mean ± SEM in panel (H).
    Blocking Solution Supplied Pla Kit, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pla+blocking+solution/duolink+kit/pmc08921220-490-20-27
    Average 90 stars, based on 1 article reviews
    blocking solution supplied pla kit - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    Image Search Results


    Loss of BTG3 leads to reduced mobility of XPC at damage sites. ( A – C ) Colocalization of BTG3 and XPC at damage sites after UV. PLA was conducted with HaCaT cells using anti-BTG3 and anti-XPC (A). Mean fluorescence intensity and PLA foci number were quantified and shown in panels (B) and (C), respectively, with n ≧ 100. Data were analyzed using unpaired two-tailed t -test and presented as mean ± SEM Scale bar, 10 μm. ( D ) Co-immunoprecipitation of endogenous BTG3 and XPC from HaCaT cells. ( E, F ) Retention of XPC at localized UV damage in BTG3 KO cells. Localized UVC-irradiation (100 J/m 2 ) was performed with 5 μM isopore membrane filter and XPC loading at localized UV damage sites was assessed using confocal microscopy (E). Scale bar, 10 μm. Percent cells with XPC-positive foci were counted and presented as mean ± SEM in panel (F). Data were analyzed using unpaired two-tailed t -test. n ≧ 50. ( G, H ) Mobility of XPC was reduced in BTG3 KO cells. The mobility of XPC-GFP in mock-treated or global UV-irradiated (20 J/m 2 ) parental and BTG3 KO HEK293T cells was assessed using FRAP. Fluorescence recovery was monitored over 120 s and normalized to prebleach intensity ( n = 36 from 3 independent experiments) (G). Data were analyzed using unpaired two-tailed t -tests and shown as mean ± SEM in panel (H).

    Journal: Nucleic Acids Research

    Article Title: BTG3-dependent VCP/p97 nuclear translocation is required for efficient repair of UV-induced DNA lesions

    doi: 10.1093/nar/gkaf626

    Figure Lengend Snippet: Loss of BTG3 leads to reduced mobility of XPC at damage sites. ( A – C ) Colocalization of BTG3 and XPC at damage sites after UV. PLA was conducted with HaCaT cells using anti-BTG3 and anti-XPC (A). Mean fluorescence intensity and PLA foci number were quantified and shown in panels (B) and (C), respectively, with n ≧ 100. Data were analyzed using unpaired two-tailed t -test and presented as mean ± SEM Scale bar, 10 μm. ( D ) Co-immunoprecipitation of endogenous BTG3 and XPC from HaCaT cells. ( E, F ) Retention of XPC at localized UV damage in BTG3 KO cells. Localized UVC-irradiation (100 J/m 2 ) was performed with 5 μM isopore membrane filter and XPC loading at localized UV damage sites was assessed using confocal microscopy (E). Scale bar, 10 μm. Percent cells with XPC-positive foci were counted and presented as mean ± SEM in panel (F). Data were analyzed using unpaired two-tailed t -test. n ≧ 50. ( G, H ) Mobility of XPC was reduced in BTG3 KO cells. The mobility of XPC-GFP in mock-treated or global UV-irradiated (20 J/m 2 ) parental and BTG3 KO HEK293T cells was assessed using FRAP. Fluorescence recovery was monitored over 120 s and normalized to prebleach intensity ( n = 36 from 3 independent experiments) (G). Data were analyzed using unpaired two-tailed t -tests and shown as mean ± SEM in panel (H).

    Article Snippet: After incubation with PLA blocking solution, HaCaT cells were incubated with anti-XPC (Santa Cruz, 1:200 dilution) and anti-BTG3 (Lab raised, 1:100 dilution) antibodies overnight at 4°C with gentle rocking.

    Techniques: Fluorescence, Two Tailed Test, Immunoprecipitation, Irradiation, Membrane, Confocal Microscopy